5Suppliers
4Customers
2Debt Items
2Related Chains

Lucid Diagnostics Inc. Suppliers

TickerNameConfidenceEvidence
BTIG-LLC BTIG-LLC 90% Pursuant to the Underwriting Agreement, the Company agreed to sell, and the Underwriters agreed to purchase, 18,000,000 shares of Common Stock
CANACCORD-GENUITY-LLC CANACCORD-GENUITY-LLC 90% Pursuant to the Underwriting Agreement, the Company agreed to sell, and the Underwriters agreed to purchase, 18,000,000 shares of Common Stock
COASTLINE-INTERNATIONAL COASTLINE-INTERNATIONAL 90% Manufacturing EsoCheck is currently manufactured for us by our partners Coastline International
SAGE-PRODUCT-DEVELOPMENT SAGE-PRODUCT-DEVELOPMENT 85% Manufacturing EsoCheck is currently manufactured for us by our partners Coastline International and Sage Product Development
CWRU CWRU 80% Under the terms of our license agreement with CWRU...we acquired an exclusive worldwide right to use the intellectual property rights to the EsoGuard and EsoCheck technology

Lucid Diagnostics Inc. Customers

TickerNameConfidenceEvidence
HEALTHCARE-PROVIDER HEALTHCARE-PROVIDER 90% The Company establishes a contract with a patient in accordance with other customary business practices, which is the point in time an order is received from a provider and a patient specimen has bee…
PHYSICIANS-AND-OTHER-MEDICAL-PROFESSIONALS PHYSICIANS-AND-OTHER-MEDICAL-PROFESSIONALS 85% We expect to ship EsoCheck devices and EsoGuard specimen kits to physicians and other medical professionals
UNRELATED-THIRD-PARTY-LEGAL-ENTITY UNRELATED-THIRD-PARTY-LEGAL-ENTITY 85% Revenue recognized is inclusive of both variable consideration in connection with an individual patient’s third-party insurance coverage policy and fixed consideration in connection with a contracted…
CLIA-CERTIFIED-LABORATORY CLIA-CERTIFIED-LABORATORY 80% have the physician’s office ship samples by air express courier delivery service to our CLIA-certified laboratory for EsoGuard testing

Lucid Diagnostics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LUCD-DEBT Debt stack $26.8M 90% Market cache reports total debt of $26.8M.
LUCD-DEBT-10817 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

Lucid Diagnostics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Lucid Diagnostics Inc..

Lucid Diagnostics Inc. Ownership

HolderNameConfidenceEvidence
LUCD-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 103 tracked holders.

Lucid Diagnostics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PAVM PAVmed Inc. 36.29 1 ['spend']
LUCID LUCID 23.09 2